key: cord-0717100-vd7gy0w5
authors: Li, Quan; Norman, Sarah; Guthrie, Pauline; Gachoya, Julianna; Sebakijje, Justin; Leftridge, Zetta; Willis, Cynthia G; Kishore, Anil; Breakenridge, Margaret; Spence, Clyde
title: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center
date: 2021-04-25
journal: Am J Health Syst Pharm
DOI: 10.1093/ajhp/zxab184
sha: f2dafafc7ddf5fbd1d4190281d8cf8d55f2d7b23
doc_id: 717100
cord_uid: vd7gy0w5

DISCLAIMER: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Highly effective coronavirus disease 2019 (COVID-19) vaccines have brought hope for ending the pandemic. Unprecedented mass vaccination started first among healthcare workers. The aim of this report is to describe key strategies undertaken by a large hospital pharmacy department to meet the challenges of preparing a large quantity of COVID-19 vaccine doses in a short period of time. SUMMARY: MedStar Washington Hospital Center (MWHC) was in the first group of hospitals in Washington, DC, to receive Pfizer-BioNTech vaccine in December 2020. The pharmacy department faced challenges including stringent vaccine storage requirements, a need for specific equipment and workflow, limited funding, and staffing constraints. The pharmacy department’s senior leaders defined pharmacy responsibilities, budgeted for equipment, participated in vaccination center design, and instructed pharmacy informatics personnel. The vaccine coordinators were appointed to oversee all vaccination-related operations. An ultra–low temperature freezer was installed 2 weeks before arrival of the first shipment of vaccine. All pharmacy order entry tools and operating procedures were standardized, and staff training and schedules were finalized by December 15. The first dose of the vaccine was administered on December 16 at the vaccination center. Pharmacy staff members dispensed the vaccine doses and monitored patients. By January 6, 2021, MWHC had vaccinated 3,812 employees with their first vaccine dose, with an average of 228 doses administered daily. CONCLUSION: Key strategies such as systemic coordination, early preparation, detailed planning, operating procedure development, and staff education and engagement proved successful in facilitating preparation of thousands of COVID-19 vaccine doses for hospital employees within a short period of time.

CoV-2) infection, use of safe and effective vaccines is the most effective approach to contain and end the pandemic. One of the first vaccines granted emergency use authorization (EUA) by the US Food and Drug Administration (FDA) is made by Pfizer and BioNTech and was shown to provide 95% protection against COVID-19 in people 16 years old or older in an ongoing multinational, placebo-controlled, observer-blinded trial. 3 Based on Centers for Disease Control and Prevention (CDC) recommendations, the top priority after granting of the EUA was to vaccinate the highest-risk populations, including healthcare personnel and residents of long-term care facilities. 4 MedStar Washington Hospital Center (MWHC), the flagship hospital of MedStar Health, is the largest tertiary academic medical center in Washington, DC. It has over 900 inpatient hospital beds, an emergency room, various ambulatory clinics, and over 7,000 employees. During the first 9 months of the COVID-19 pandemic, MWHC treated up to 200 patients with COVID-19 daily. It was identified by the Washington, DC, department of health (DC-DOH) to not only receive and administer the Pfizer-BioNTech COVID-19 vaccine inside MWHC but also transfer COVID-19 vaccines to 2 nearby hospitals. The aim of this report is to describe how the pharmacy department responded to unprecedented challenges to provide Pfizer-BioNTech vaccine to hospital associates through systemic leadership A c c e p t e d M a n u s c r i p t coordination, protocol development, staff engagement and training, and collaboration with other healthcare professionals.

MWHC was among the first groups of hospitals to receive the Pfizer-BioNTech vaccine. Unlike other FDA-approved vaccines, Pfizer-BioNTech vaccine required especially stringent handling conditions. The vaccine stock needed to be kept frozen at no higher than -60°C to maintain its efficacy. Prior to reconstitution the vaccine had to be thawed. Once reconstituted, it was only stable for 6 hours at room temperature. Each vial contained 5 or 6 doses, and individual doses needed to be drawn immediately before administration.

Furthermore, the vaccine series required a second dose 21 days after the first administration. As a result, the pharmacy department faced several major challenges:

 The pharmacy department did not have a large ultra-low temperature freezer. therapeutic treatments, such as remdesivir, bamlanivimab, and casirivimab/imdevimab, and A c c e p t e d M a n u s c r i p t had participated in the development of hospital COVID-19 treatment guidelines. At the same time, the pharmacy department leadership realized the potential for future vaccination efforts since the summer of 2020 and followed the progression of vaccine development and clinical trials closely. When the COVID-19 vaccination task was assigned, the pharmacy leadership team first developed departmental strategies ( Figure 1 ) to be aligned with the federal and state regulations, including those of CDC, FDA, and DC-DOH.

The pharmacy department contacted DC-DOH to confirm the type of vaccine and quantities of vaccine the hospital would receive and clarified associated regulatory requirements.

Next, the pharmacy department worked with the hospital leadership team, including hospital administrators, providers, and nursing staff, to define responsibilities of the pharmacy department in vaccine preparation and dispensing as well as roles in the planned vaccination center. Based on the defined vaccination needs, the pharmacy department leadership developed plans to rearrange the current workforce, optimize workflow, purchase and install the required equipment, and seek support from internal and pro re nata (PRN) staff. Most importantly, the pharmacy leadership team appointed a primary vaccine coordinator from among the pharmacy managers, along with an alternate, to be in charge of the vaccination-related initiatives. The primary vaccine coordinator and the alternate had the following responsibilities: After vaccination, patients were monitored for any immediate adverse events for 15 minutes (30 minutes for patients with a history of any allergy) and given the vaccination information sheet and CDC vaccination card. Finally, patients checked out at any available vaccination bay, and the registration staff scheduled them for their next appointment.

Associates were reminded to self-monitor for common and serious adverse effects and instructed to report to occupational health personnel or the emergency room according to the severity of signs and symptoms.

Pharmacy staff were the only team members that prepared the vaccine doses. One pharmacy staff member was responsible for drawing up a dose into a syringe with aseptic technique at the designated pharmacy station; a second pharmacy staff member was responsible for double-checking the volume, labeling each syringe, and delivering each dose to each vaccination bay; and a third pharmacy staff member was responsible for verifying 

The MWHC vaccination center opened at 7 AM on December 16, 2020, and was 

Highly effective COVID-19 vaccines have brought hope for ending the pandemic that is rampaging in the United State and around the world. However, mass immunization with COVID-19 vaccine has brought unprecedented challenges to hospital pharmacies, including stringent vaccine storage requirements, a need for specific equipment and workflow, insufficient funding, and staffing challenges. Lessons had to be continually learned in order to overcome these hurdles and successfully roll out an early-phase vaccination plan in a short period of time.

A strong pharmacy management team was critical for the success of this mission.

The team fully understood the task, evaluated available resources and potential barriers, immunization-certified pharmacy staff could also administer the vaccine, a practice endorsed by recently issued ASHP guidelines. 6 ) There was a sufficient number of vaccinators, who were enlisted from other healthcare disciplines, but MWHC immunizationcertified pharmacists were ready to extend services to help more associates if needed.

As there was high demand with limited initial vaccine allocation, it was necessary to prioritize vaccination based on an associate's level of risk for contracting COVID-19. Highrisk associates included those working in areas such as the emergency department, air transportation, designated COVID-19 units, critical care units, labor and delivery, anesthesiology, and rapid response teams, and they were offered vaccine appointments first. The next highest-risk group of people were those with any direct patient contact. Once those associates were offered vaccination, it was offered to any associate, including hospital administrators and department leaders. In addition, the hospital and the pharmacy department sent out vaccine information and answers to common questions to all employees, strongly encouraging but not mandating that associates register for vaccination.

From December 16, 2020, to January 6, 2021, MWHC vaccinated approximately 50% of associates with their first dose. While administration of second doses began after that, staff continued to register for the first dose of the vaccine. MWHC's associate vaccination rate was over 60% at the end of February 2021, lower than the goal of 70% to 85% but similar to reported rates at other institutions nationwide. At the time of writing, planning was underway for efforts to identify reasons associates refused to receive the vaccine and work with them to address those concerns. 

The urgent need for mass administration of Pfizer-BioNTech COVID-19 vaccine brought many unprecedented challenges to hospital pharmacies due to the vaccine's storage and preparation characteristics and limited time and resources for vaccination efforts. However, pharmacy departments could use the key strategies described hereformation of a strong leadership team, systemic coordination, SOP development, staff training and engagement, and multidisciplinary teamwork-to facilitate completion of M a n u s c r i p t 

 Early COVID-19 mass vaccination efforts brought unprecedented challenges to hospital system pharmacies, including stringent vaccine storage requirements, a need for specific equipment and workflow, and staffing challenges. A c c e p t e d M a n u s c r i p t 

World Health Organization. Coronavirus disease (COVID-19) pandemic

Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine

The Advisory Committee on Immunization Practices' updated interim recommendation for allocation of COVID-19 vaccine -United States

Pfizer-BioNTech COVID-19 vaccine

ASHP principles for COVID-19 vaccine distribution, allocation, and mass immunization

A c c e p t e d M a n u s c r i p t